SciCombinator

Discover the most talked about and latest scientific content & concepts.

I Schwab and F Nimmerjahn
Abstract
Intravenous immunoglobulin (IVIG) preparations comprise pooled IgG antibodies from the serum of thousands of donors and were initially used as an IgG replacement therapy in immunocompromised patients. Since the discovery, more than 30 years ago, that IVIG therapy can ameliorate immune thrombocytopenia, the use of IVIG preparations has been extended to a wide range of autoimmune and inflammatory diseases. Despite the broad efficacy of IVIG therapy, its modes of action remain unclear. In this Review, we cover the recent insights into the molecular and cellular pathways that are involved in IVIG-mediated immunosuppression, with a particular focus on IVIG as a therapy for IgG-dependent autoimmune diseases.
Tweets*
11
Facebook likes*
3
Reddit*
0
News coverage*
1
Blogs*
0
SC clicks
1
Concepts
Antigen, Immunosuppressive drug, Immunity, Humoral immunity, Antibody, Immunology, Intravenous immunoglobulin, Immune system
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com